Evidence map›Paper›PMID 41188323›Full record

ArticleScientific reports2025

Web based AI-driven framework combining multi-modal data with CNN and LLM for Parkinson's disease diagnosis.

Priyadharshini S, Ramkumar K, Narasimhan K, V B Surya Prasath, Venkatesh S

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Priyadharshini SDepartment of Electrical and Electronics Engineering, Saveetha Engineering College, Chennai, Tamil Nadu, India. spriyadharshini@saveetha.ac.in.
Ramkumar KSchool of Computing, SASTRA Deemed University, Thanjavur, India. ramkumar@eie.sastra.edu.
Narasimhan KSchool of Electrical and Electronics Engineering, SASTRA Deemed University, Thanjavur, India.
V B Surya PrasathDepartment of Biomedical Informatics, College of Medicine, University of Cincinnati, Cincinnati, OH, 45267, USA.
Venkatesh SSchool of Electrical and Electronics Engineering, SASTRA Deemed University, Thanjavur, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by a wide spectrum of motor and non-motor symptoms, often leading to delayed or inaccurate diagnosis. Conventional diagnostic methods frequently suffer from limited sensitivity, scalability, and interpretability, thereby restricting their utility in clinical settings. To address these limitations, this study presents a novel AI-driven diagnostic framework that integrates multimodal data fusion, deep learning-based classification, and generative language modeling to improve diagnostic accuracy and enable personalized reporting. The proposed framework leverages the Parkinson's Progression Marker Initiative (PPMI) dataset, incorporating structural Magnetic resonance imaging (MRI), Single-Photon Emission Computed Tomography (SPECT) imaging, cerebrospinal fluid (CSF) biomarkers, and clinical assessments. Statistical analysis was employed to select 14 key biomarkers-including dopamine transporter SBR values and CSF protein levels-from a total of 21 features identified as clinically relevant. A 1D Convolutional Neural Network (1D-CNN) was developed and trained using 121 engineered features, comprising radiomic descriptors and biologically derived metrics. Preprocessing and extensive feature engineering were conducted prior to a 70:30 train-test split, with data augmentation applied to the training set to enhance model generalization. The classifier achieved an accuracy of 93.7%, surpassing baseline approaches and emphasizing the value of domain-informed feature design. To improve interpretability and clinician usability, a Mini ChatGPT-4.0 Large Language Model (LLM) was fine-tuned using approximately 1,000 domain-specific prompt-response pairs generated from literature, classifier-derived eXplainable AI (XAI) feature scores, and expert annotations. The generated responses were evaluated using a custom scoring metric (0.0-5.0) based on their semantic alignment with ground truth completions. This LLM module produces patient-specific diagnostic summaries and treatment suggestions. Additionally, a cloud-based interface was developed to facilitate real-time MRI uploads, automated inference, and chatbot-driven consultations. Overall, the framework demonstrates high diagnostic performance, transparency, and user accessibility, offering significant potential for real-world clinical deployment in PD diagnosis and decision support.

Indexed as

Neural Networks, ComputerParkinson DiseaseBiomarkersDeep LearningHumansInternetMagnetic Resonance ImagingTomography, Emission-Computed, Single-PhotonBiomarkersClinical decision support systemsCloud-Based Diagnostic PlatformFine-tuned LLMMultimodal data analysisPD diagnosisPersonalized medical report

Identifiers

PMID41188323
PMCPMC12586488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.